Tested batch: EP-260519-SE05
Sermorelin (5mg) is supplied as a research compound for laboratory use only. Each box contains 10 vials of lyophilized powder, with 5mg of Sermorelin per vial.
Specifications: SKU SMO5 · 10 vials of lyophilised powder per box · 5mg per vial · measured net content 5.34 mg. Testing: four Kovera Labs reports for batch EP-260519-SE05: RP-HPLC purity 98.909% with LC-MS identity, endotoxin < 0.20 EU/mL, heavy metals and sterility – see the certificates below. Further reading: Sermorelin in Australia: product overview and Sermorelin: a research guide to evaluating suppliers. For laboratory research use only; not for human consumption.
Free shipping on all products.
This product is strictly intended for laboratory research use only. Not for human consumption. All products sold are for research purposes and should only be handled by qualified professionals in a controlled laboratory environment.
Tested batch: EP-260519-SE05 · 4 published certificates. Report library updated .
Batch EP-260519-SE05 – four Kovera Labs reports. Purity and identity: RP-HPLC purity 98.909%, net content 5.34 mg, LC-MS identity: Sermorelin (KVR-2026-F64B17, 30 June 2026). Endotoxin: < 0.20 EU/mL (ENDO-KVR-2026-F64B17). Heavy metals: lead < 0.5, arsenic < 0.15, cadmium < 0.05 and mercury < 0.3 ppm (HM-KVR-2026-F64B17). Sterility: no bacterial growth (aerobic and anaerobic) and no fungi or yeast detected after a 2-day incubation (RSTER-KVR-2026-F64B17). Each certificate links to its Kovera Labs verification record, and the product image shows the same batch reference. For laboratory research use only.
| Test | Reported result | Report ID | Report date |
|---|---|---|---|
| Purity and Identity (COA) | Purity: 98.909 %; Net content: 5.34 mg; Identity confirmation: Sermorelin | KVR-2026-F64B17 | 30 June 2026 |
| Endotoxin | Endotoxin: < 0.20 EU/mL | ENDO-KVR-2026-F64B17 | 30 May 2026 |
| Heavy Metals | Lead: < 0.5 ppm; Arsenic: < 0.15 ppm; Cadmium: < 0.05 ppm; Mercury: < 0.3 ppm | HM-KVR-2026-F64B17 | 31 May 2026 |
| Sterility testing | Bacteria (aerobic/anaerobic): No Growth; Fungi / yeast: Not Detected; Incubation period: 2 days | RSTER-KVR-2026-F64B17 | 30 May 2026 |
Read how to interpret and verify a Kovera Labs report or browse our testing standards and report directory.
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Purity | 98.909 % | — | RP-HPLC |
| Net content | 5.34 mg | — | — |
| Identity confirmation | Sermorelin | — | LC-MS |
| Endotoxin screen | PASS | — | — |
| Microbial sterility screen | No Growth | — | — |
| Arsenic (As) screening | Negative | — | — |
| Cadmium (Cd) screening | Negative | — | — |
| Lead (Pb) screening | Negative | — | — |
| Mercury (Hg) screening | Negative | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Endotoxin | < 0.20 EU/mL | ≤ 0.5 | — |
| Final determination | PASS | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Lead | < 0.5 ppm | ≤ 10 | ICP-MS |
| Arsenic | < 0.15 ppm | ≤ 1.5 | ICP-MS |
| Cadmium | < 0.05 ppm | ≤ 0.5 | ICP-MS |
| Mercury | < 0.3 ppm | ≤ 3 | ICP-MS |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Bacteria (aerobic/anaerobic) | No Growth | — | — |
| Fungi / yeast | Not Detected | — | — |
| Incubation period | 2 days | — | — |
| Temperature | 30-35C | — | — |
| Final determination | SAMPLE PASSES STERILITY SCREEN | — | — |
Evidence reviews and laboratory guides relevant to Sermorelin 5mg, plus the testing behind each batch.
Explore Sermorelin research, Australian buying guides and laboratory documentation.
